Acelyrin (NASDAQ: SLRN)
Some price data may be temporarily unavailable.
Acelyrin Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Acelyrin Company Info
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
News & Analysis
Featured Article
Highest-Paid CEOs in 2025
You'll be shocked to learn how much these executives earn annually.
Catherine Brock | Nov 8, 2023
Featured Article
Why Acelyrin Stock Plummeted 59% This Week
The recently public biopharma company announced disappointing results from a clinical trial of its lead drug candidate.
Steve Symington | Sep 15, 2023
Valuation
Earnings Transcripts
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.